The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
COVID-19 patients who have a stroke are more than twice as likely to die than uninfected stroke patients and are often younger and healthier, finds research presented yesterday at the Society of NeuroInterventional Surgery’s (SNIS's) 19th Annual Meeting in Toronto.
Vaccine contracts with both Moderna and Pfizer come ahead of booster dose campaigns expected to begin in September.
Though vaccine hesitancy plays a role, decreased access to vaccination sites may be another overlooked barrier, researchers suggest.
A systematic review and meta-analysis published yesterday in BMJ estimates that 5.6% of COVID-19 survivors may face long-lasting changes to their sense of smell or taste, adding to concerns about the overall burden of long COVID.
Of hospitalized COVID patients, 53% still had brain fog 13 months later.
Studies suggest the market didn't just amplify virus spread, it was the early epicenter and site of SARS-CoV-2 emergence.
Completion of a primary COVID-19 vaccination series after recovery from infection was tied to half the risk of reinfection in the pre-Omicron variant era, according to a study published today in JAMA Network Open.
More broadly protective vaccines and ones that can block transmission and infection are among the next-generation vaccine goals.
The risk of myocarditis and/or pericarditis was not significantly different among children ages 5 to 11 years after COVID-19 vaccination from that of unvaccinated children and much lower than that among children aged 12 to 17, finds a prospective study in Denmark published today in Pediatrics.
Paxlovid and molnupiravir stood out in a meta-analysis that compared the effectiveness of 16 different drug or drug combinations.
